
Zhejiang
603896.SSZhejiang Shouxiangu Pharmaceutical Co., Ltd. Price (603896.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
195,753,891
(1.6677)%Revenue and Profitability
Year | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 177,752,928 | 253,030,064 | 301,591,563 | 301,912,435 | 314,879,954 | 369,963,314 | 511,451,922 | 546,758,533 | 636,050,563 | 767,137,327 | 829,071,599 | 784,347,256 |
Net Income | 34,022,821 | 54,048,128 | 69,251,164 | 62,643,861 | 80,977,816 | 88,879,887 | 107,652,897 | 123,895,326 | 151,712,138 | 200,826,526 | 277,783,036 | 254,480,058 |
FCF USD | -2,944,948 | -47,620,845 | -33,267,384 | -45,843,689 | 55,266,819 | 79,355,789 | -61,329,770 | 116,432,259 | 191,379,855 | 135,073,996 | 158,682,880 | -99,482,965 |
OCF USD | 45,356,807 | 65,849,813 | 102,899,075 | 85,029,300 | 95,516,877 | 110,803,595 | 171,513,111 | 207,918,192 | 256,358,637 | 296,699,128 | 341,283,418 | 315,057,383 |
Financial Health - DEBT
Year | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
YTPD | 0.00 | 0.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.24 | 0.50 | 1.54 | 1.43 |
D/E | 0.36 | 0.18 | 0.32 | 0.45 | 0.28 | 0.00 | 0.04 | 0.01 | 0.14 | 0.07 | 0.37 | 0.34 |
CA/CL | 1.26 | 2.56 | 0.83 | 0.71 | 1.01 | 10.06 | 2.72 | 4.12 | 5.60 | 5.25 | 3.90 | 3.09 |
TA/TL | 2.02 | 3.73 | 2.78 | 2.55 | 3.49 | 16.37 | 5.76 | 7.97 | 4.55 | 5.73 | 3.00 | 3.16 |
Total Debt | 50,000,000 | 54,500,000 | 104,000,000 | 167,600,000 | 123,000,000 | 0 | 40,000,000 | 10,000,000 | 188,126,311 | 106,561,584 | 706,406,104 | 736,318,278 |
Management Performance
Year | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ROIC | 15.42% | 14.31% | 15.28% | 10.50% | 12.47% | 10.35% | 10.41% | 10.52% | 10.22% | 11.71% | 10.58% | 8.59% |
ROE | 24.59% | 18.05% | 21.60% | 17.00% | 18.53% | 10.22% | 10.93% | 10.57% | 11.44% | 12.40% | 14.58% | 11.72% |
ROA | 0.00% | 13.20% | 13.82% | 10.34% | 13.23% | 9.59% | 9.03% | 9.24% | 8.93% | 10.21% | 9.72% | 8.02% |
NM % | 19.14% | 21.36% | 22.96% | 20.75% | 25.72% | 24.02% | 21.05% | 22.66% | 23.85% | 26.18% | 33.51% | 32.44% |
FCF / R% | 0.00% | -18.82% | -11.03% | -15.18% | 17.55% | 21.45% | -11.99% | 21.30% | 30.09% | 17.61% | 19.14% | -12.68% |
FCF / NI% | -8.66% | -88.11% | -48.04% | -73.18% | 68.25% | 89.28% | -56.97% | 93.98% | 126.15% | 67.43% | 57.18% | -39.09% |
Operating Margin (OM) | 0.00 | 0.19 | 0.21 | 0.34 | 0.52 | 0.61 | 0.57 | 0.69 | 0.74 | 0.80 | 0.98 | 1.24 |
Per Share
Year | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS | 0.32 | 0.52 | 0.51 | 0.46 | 0.59 | 0.55 | 0.59 | 0.68 | 0.82 | 1.04 | 1.44 | 1.30 |
SPS | 1.69 | 2.41 | 2.21 | 2.22 | 2.30 | 2.27 | 2.81 | 2.99 | 3.45 | 3.96 | 4.31 | 4.01 |
OCPS | 0.43 | 0.63 | 0.75 | 0.63 | 0.70 | 0.68 | 0.94 | 1.14 | 1.39 | 1.53 | 1.77 | 1.61 |
FCPS | -0.03 | -0.45 | -0.24 | -0.34 | 0.40 | 0.49 | -0.34 | 0.64 | 1.04 | 0.70 | 0.82 | -0.51 |
BVPS | 1.32 | 2.85 | 2.35 | 2.72 | 3.20 | 5.34 | 5.42 | 6.41 | 7.20 | 8.37 | 9.90 | 11.09 |
Per Share - CAGR
Year | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
CAGR-EPS | 0.32 | 0.52 | 0.51 | 0.46 | 0.59 | 0.55 | 0.59 | 0.68 | 0.82 | 1.04 | 1.44 | 1.30 |
CAGR-SPS | 1.69 | 2.41 | 2.21 | 2.22 | 2.30 | 2.27 | 2.81 | 2.99 | 3.45 | 3.96 | 4.31 | 4.01 |
CAGR-OCPS | 0.43 | 0.63 | 0.75 | 0.63 | 0.70 | 0.68 | 0.94 | 1.14 | 1.39 | 1.53 | 1.77 | 1.61 |
CAGR-FCPS | -0.03 | -0.45 | -0.24 | -0.34 | 0.40 | 0.49 | -0.34 | 0.64 | 1.04 | 0.70 | 0.82 | -0.51 |
CAGR-BVPS | 1.32 | 2.85 | 2.35 | 2.72 | 3.20 | 5.34 | 5.42 | 6.41 | 7.20 | 8.37 | 9.90 | 11.09 |